Salt-Adapted Microorganisms: A Promising Resource for Novel Anti-Cancer Drug Discovery
Marine Drugs · 2025
DOI: 10.3390/md23080296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Longteng Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Discovery, Neoplasms, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinjiang Uygur Autonomous Region Tianchi Talent Introduction Program-Young Doctor, Tianchi Innovation Leading Talent Project.
Abstract (Originalsprache)
Microorganisms serve as a vital source of natural anticancer agents, with many of their secondary metabolites already employed in clinical oncology. In recent years, salt-adapted microbes, including halophilic and halotolerant species from marine, salt lake, and other high-salinity environments, have gained significant attention. Their unique adaptation mechanisms and diverse secondary metabolites offer promising potential for novel anticancer drug discovery. This review consolidated two decades of research alongside current global cancer statistics to evaluate the therapeutic potential of salt-adapted microorganisms. Halophilic and halotolerant species demonstrate significant promise, with their bioactive metabolites exhibiting potent inhibitory effects against major cancer cell lines, particularly in lung and breast cancer. Evidence reveals structurally unique secondary metabolites displaying enhanced cytotoxicity compared to conventional anticancer drugs. Collectively, salt-adapted microorganisms represent an underexplored yet high-value resource for novel anticancer agents, offering potential solutions to chemotherapy resistance and treatment-related toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
- School of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
- Analysis and Testing Center, Shenyang University of Chemical Technology, Shenyang 110142, China.
- Arkansas Biosciences Institute, Arkansas State University, Jonesboro, AR 72401, USA.
ORCID-Profile: Shiyang Lu, Dong Wang, Amit Raj Sharma
Förderung
- Xinjiang Uygur Autonomous Region Tianchi Talent Introduction Program-Young Doctor
- Tianchi Innovation Leading Talent Project
Zitieren
APA
Fang, L., Xu, L., Kader, M., Ding, T., Lu, S., Wang, D., Sharma, A. R., & Zhang, Z. (2025). Salt-Adapted Microorganisms: A Promising Resource for Novel Anti-Cancer Drug Discovery. Marine Drugs. https://doi.org/10.3390/md23080296
Vancouver
Fang L, Xu L, Kader M, Ding T, Lu S, Wang D, et al. Salt-Adapted Microorganisms: A Promising Resource for Novel Anti-Cancer Drug Discovery. Marine Drugs. 2025. doi:10.3390/md23080296
BibTeX
@article{Fang2025,
author = {Fang, Longteng and Xu, Liping and Kader, Marhaba and Ding, Tingting and Lu, Shiyang and Wang, Dong and Sharma, Amit Raj and Zhang, Zhiwei},
title = {Salt-Adapted Microorganisms: A Promising Resource for Novel Anti-Cancer Drug Discovery},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23080296}
}
EUVIMED